scispace - formally typeset
M

María Honrubia Pérez

Researcher at Boston Children's Hospital

Publications -  67
Citations -  792

María Honrubia Pérez is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Information system & Population. The author has an hindex of 17, co-authored 67 publications receiving 697 citations. Previous affiliations of María Honrubia Pérez include Centro de Investigación y Desarrollo Tecnológico en Electroquímica & National Scientific and Technical Research Council.

Papers
More filters
Journal ArticleDOI

Lactobacillus plantarum CECT7315 and CECT7316 stimulate immunoglobulin production after influenza vaccination in elderly

TL;DR: L. plantarum CECT7315/7316 has an immunostimulating effect and could be used to improve the response to influenza vaccination in elderly, and increased the levels of influenza-specific IgA and IgG antibodies.
Journal ArticleDOI

Outcomes of children with proliferative lupus nephritis: the role of protocol renal biopsy

TL;DR: Clinical and biopsy results greatly improved after 9 monthly intravenously administered CYP pulses in most children with class IV PLN and the tailoring of therapies based on findings from a biopsy after induction may improve outcomes.
Journal ArticleDOI

Effects of electrode material on the efficiency of hydrocarbon removal by an electrokinetic remediation process

TL;DR: In this paper, the feasibility of removing hydrocarbon from a polluted soil, analyzing first some properties of different electrode materials by electrochemical techniques for the purpose of selecting the best to be used as an anode in the electrokinetic process.
Journal ArticleDOI

A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: II. The comparison of bleeding patterns

TL;DR: The analysis suggests how the life-table analysis of discontinuation reasons underestimates the true incidence of vaginal bleeding irregularities in a clinical trial.